about
Association of sarcoidosis and immune thrombocytopenia: presentation and outcome in a series of 20 patients.Conditioned media from mesenchymal stromal cells restore sodium transport and preserve epithelial permeability in an in vitro model of acute alveolar injury.Pulmonary hypertension complicating sarcoidosis.Adult Onset Asthma and Periocular Xanthogranuloma (AAPOX), a Rare Entity With a Strong Link to IgG4-Related Disease: An Observational Case Report Study.Imaging of sarcoidosis of the airways and lung parenchyma and correlation with lung function.Clinical presentation of sarcoidosis and diagnostic work-up.Mesenchymal stem cells protect from hypoxia-induced alveolar epithelial-mesenchymal transition.Involvement of NK Cells and NKp30 Pathway in Antisynthetase Syndrome.The Lung in Dysregulated States of Humoral Immunity.Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: Common Interferon Signature but Distinct NOS2 Expression.Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris.Dendritic cells accumulate in human fibrotic interstitial lung disease.Chronic urticaria and monoclonal IgM gammopathy (Schnitzler syndrome): report of 11 cases treated with pefloxacin.Stage IV sarcoidosis: comparison of survival with the general population and causes of death.18F-fluorodeoxyglucose positron emission tomography/computer tomography as an objective tool for assessing disease activity in Sjögren's syndrome.Mesenchymal stem cells reduce hypoxia-induced apoptosis in alveolar epithelial cells by modulating HIF and ROS hypoxic signalings.Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity.In Vivo Tissue Engineering of Human Airways.Bronchial Involvement in Rosai Dorfman Disease.Nonspecific interstitial pneumonia: survival is influenced by the underlying cause.Blood ferritin and isoferritins measurements may be helpful in acute respiratory distress syndrome patients.Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival.[Lung sarcoidosis: Clinical features and therapeutic issues].[Thoracic sarcoidosis].Comment on: rituximab in autoimmune connective tissue disease-associated interstitial lung disease.Detection and follow-up of fibroblast growth factor receptor 3 expression on bone marrow and circulating plasma cells by flow cytometry in patients with t(4;14) multiple myeloma.Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodiesHIF-1α triggers ER stress and CHOP-mediated apoptosis in alveolar epithelial cells, a key event in pulmonary fibrosisHemorrhagic bullous colitis as a primary manifestation of AL amyloidosis[Atypical sarcoidosis][The specific pulmonary manifestations of acute myeloid leukaemia][Lung involvement in lymphoid and lympho-plasmocytic proliferations (except lymphomas)][Innovative therapeutics for idiopathic pulmonary fibrosis]SarcoidosisHypoxia-induced inhibition of epithelial Na(+) channels in the lung. Role of Nedd4-2 and the ubiquitin-proteasome pathwayEpidemiology of primary Sjögren's syndrome in a French multiracial/multiethnic areaSarcoidosis in Patients with Antisynthetase Syndrome: Presentation and OutcomeImmunopathogenesis of the Anti-Synthetase SyndromeLower respiratory tract amyloidosis: Presentation, survival and prognostic factors. A multicenter consecutive case seriesLung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patients
P50
Q33395874-A0894BB6-AF9B-4655-BF7F-F07998013D84Q33701911-D2409706-2D0A-4525-A205-A597E67420A5Q34276008-A8DC27E0-38E9-47FD-BEE3-18281F6AA007Q37176382-2F6C42EA-22E0-4421-8E98-2BED1B98E0D7Q38025955-117D171C-4C8C-4418-985D-CCEA12BA8E26Q38227641-9B1DC132-29AE-425D-85A5-5D334A8F11AFQ38809230-C2CD2765-B7E9-4A54-A064-3D7A90BC3DF7Q39501862-1D059008-90E3-4E05-AB01-BABC6CBE1BAEQ40045962-88D65BFA-4D72-46C7-B532-B84EA9CD676DQ40066688-E4807172-635E-43CF-A8B2-1BC5C6E63FC4Q40095447-6AFFC40F-6E29-421A-BA06-BF476D033717Q40180589-B98ACE16-8361-4D5E-8517-A136D325179DQ40441488-9534706E-1D0D-401A-8DBA-728BFE19E317Q43800062-339538D4-067D-4CDE-BB0C-805FF5E86E44Q45773785-5852CFEE-A316-4431-A716-F053CA32969BQ46255829-EEDA2688-41EA-4BFB-BF6A-ABDAD7351FF0Q47409630-7043E691-C6D0-4699-BF4F-DADC89B9BDFDQ47992661-C940B56F-B249-4428-B5FC-7A3EDBF1ED4EQ49888890-BA794334-D3AF-4B9B-A663-9C829F0449BCQ51672741-AF14932C-5481-45E8-B8E1-DB4B8D41FBDEQ51702793-21477DA7-8ED0-45C4-8037-E1413A5B80B2Q53121309-B9482D51-A3DF-4922-8482-DE47A6692F86Q53169976-D5DE2552-3128-4587-B995-B1F0DEC9DC33Q53321024-3EC97C9A-1832-4FD6-B716-2C5876F541C0Q54444891-5FE1AFFF-F55B-48B5-99DE-2E4C6CF3CCC7Q54562253-DAC55701-2F07-4CB6-A4CB-36BAB33EFAD2Q57612925-4F495F4E-F082-49AB-A278-69B264FE9D89Q60301420-69A3ED3C-DD45-42BA-A59F-A389103978FBQ79967100-BFA13354-72FA-4F4A-BBB5-EEB3AED1FA56Q80134468-25EAA3C2-4A46-4C35-B462-57B4EDF47CF8Q84539960-FB83D547-9A99-4891-8E8A-368CE82F789BQ84539965-0D5F942C-8C47-4B57-8549-0E56A98C3FB5Q84886339-890C545E-E4D9-4425-A220-9D31580D0C06Q86442315-E477410C-E882-4D04-B3FF-EAEE77ABDC1FQ86451250-57330BFD-8D23-4230-A1CC-E4CC531BE878Q87319423-CFEDCF3B-4317-4AE7-BE9A-31DA303BF952Q89367958-D805B2B9-B230-40FB-A2A8-01F3DCE64FA0Q91921624-A2775D96-EB72-461F-8733-ABB9093EBE07Q92515972-9E206F1D-346C-4901-A24A-F5958F1AB031Q95652936-FB00A63D-A9A0-4EA5-8F31-24B206070BBF
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Yurdagul Uzunhan
@ast
Yurdagul Uzunhan
@nl
Yurdagul Uzunhan
@sl
Yurdagül Uzunhan
@en
Yurdagül Uzunhan
@es
Yurdagül Uzunhan
@pt
Yurdagül Uzunhan
@tr
type
label
Yurdagul Uzunhan
@ast
Yurdagul Uzunhan
@nl
Yurdagul Uzunhan
@sl
Yurdagül Uzunhan
@en
Yurdagül Uzunhan
@es
Yurdagül Uzunhan
@pt
Yurdagül Uzunhan
@tr
altLabel
Yurdagul Uzunhan
@en
prefLabel
Yurdagul Uzunhan
@ast
Yurdagul Uzunhan
@nl
Yurdagul Uzunhan
@sl
Yurdagül Uzunhan
@en
Yurdagül Uzunhan
@es
Yurdagül Uzunhan
@pt
Yurdagül Uzunhan
@tr
P1053
P-5437-2017
P106
P1559
Yurdagül Uzunhan
@tr
P21
P31
P3829
P496
0000-0002-1607-1407
P569
2000-01-01T00:00:00Z